Dr. David S. Willcutts, MD
Pediatric Gastroenterology (Pediatric Gastroenterology Physician)
At a glance
- In the NPI registry since
- 2017
Licensed in Alabama since 2024, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2017Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Gastroenterology Physician primary
AL license MD.49399 (first issued 2024; active) -
Pediatrics Physician
AL license MD.49399 (first issued 2024; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 1 companies reported 14 payments worth $4,496 in total to this clinician.
| Mirum Pharmaceuticals, Inc. | $4,496 |
|---|
| Consulting Fee | $2,600 |
|---|---|
| Travel and Lodging | $1,618 |
| Food and Beverage | $278 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. Oct 3, 2025 | Consulting Fee Livmarli · Alagille syndrome | $2,600 |
| Mirum Pharmaceuticals, Inc. Oct 3, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Boston, MA | $659 |
| Mirum Pharmaceuticals, Inc. Oct 3, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Boston, MA | $459 |
| Mirum Pharmaceuticals, Inc. Oct 3, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Boston, MA | $428 |
| Mirum Pharmaceuticals, Inc. Oct 3, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Boston, MA | $35.87 |
| Mirum Pharmaceuticals, Inc. Oct 3, 2025 | Travel and Lodging Livmarli · Alagille syndrome · travel to Boston, MA | $35.52 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.